Tenofovir to Prevent HBV Reactivation
Condition(s):Hepatitis B; Lymphoma; Non-HodgkinLast Updated:December 12, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Hepatitis B; Lymphoma; Non-HodgkinLast Updated:December 12, 2019Unknown status
Condition(s):Pharmacokinetics of 1% Tenofovir Gel Following Coitus; Pharmacodynamics of 1% Tenofovir Gel Following CoitusLast Updated:June 28, 2021Completed
Condition(s):Chronic Hepatitis BLast Updated:March 29, 2021Completed
Condition(s):Hepatitis BLast Updated:June 5, 2019Terminated
Condition(s):Healthy VolunteerLast Updated:November 2, 2016Completed
Condition(s):HBeAg-positive Chronic Hepatitis BLast Updated:October 10, 2023Completed
Condition(s):HBeAg-negative Chronic Hepatitis BLast Updated:September 25, 2023Completed
Condition(s):HepatitisLast Updated:January 26, 2017Completed
Condition(s):HIV InfectionsLast Updated:June 24, 2005Unknown status
Condition(s):Chronic Hepatitis BLast Updated:March 19, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.